Author

H. Wu

Institutions: Henan Cancer Hospital, University at Buffalo, State University of New York

Observed institutions: Henan Cancer Hospital, University at Buffalo, State University of New York

ORCID: 0009-0007-7687-1514

Observed ORCID: 0009-0007-7687-1514

OpenAlex ID: A5061880859

Becotatug vedotin for recurrent/metastatic nasopharyngeal carcinoma (Magic-M001): a multicenter, randomized trial

2026 · F. Han, Y.Q. Xiang, et al. · Annals of Oncology · 7

Caspase-8 Mutation Promotes HNSCC Development and Resistance to Anti–PD-1

2026 · Z. Cui, H. Wu, et al. · Journal of Dental Research

PO-1079 An optimal assessment schedule in the head and neck cancer using parametric modeling

2022 · H.I. Lee, J. Lee, et al. · Radiotherapy and Oncology

PD-0823 Adjuvant Radiotherapy for Node-negative Parotid Gland Cancer Patients Undergoing Curative Resection

2022 · J.B. Park, H. Wu, et al. · Radiotherapy and Oncology

Works count: 4

Citation count: 7

H-index: 1

I10-index: